UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 04, 2023
Accession Number:0001640455-23-000096
Submission Type:POS AM
CIK:0001640455
Company Name:Jounce Therapeutics, Inc.
File Number:333-223518
Jounce Therapeutics (NASDAQ:JNCE)
Historical Stock Chart
Von Mär 2025 bis Apr 2025 Click Here for more Jounce Therapeutics Charts.
Jounce Therapeutics (NASDAQ:JNCE)
Historical Stock Chart
Von Apr 2024 bis Apr 2025 Click Here for more Jounce Therapeutics Charts.